{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:50:22Z","timestamp":1789023022332,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.nbd.2020.104785","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T04:26:57Z","timestamp":1582259217000},"page":"104785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations"],"prefix":"10.1016","volume":"138","author":[{"given":"Anna A.","family":"Pimenova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Goate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2020.104785_bb0005","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using CRISPR-Cas9 system","volume":"8","author":"Ann Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.nbd.2020.104785_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-017-0268-4","article-title":"Stem cell models of Alzheimer\u2019s disease: progress and challenges","volume":"9","author":"Arber","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.nbd.2020.104785_bb0015","first-page":"1","article-title":"Amyloid precursor protein processing in human neurons with an allelic series of the PSEN1 intron 4 deletion mutation and total presenilin-1 knockout","author":"Arber","year":"2019","journal-title":"Brain Commun."},{"key":"10.1016\/j.nbd.2020.104785_bb0020","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1001\/jama.286.18.2257","article-title":"A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families","volume":"286","author":"Athan","year":"2001","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.nbd.2020.104785_bb0025","first-page":"1","article-title":"Generation of genomic deletions in mammalian cell lines via CRISPR\/Cas9","author":"Bauer","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.nbd.2020.104785_bb0030","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/emboj.2012.79","article-title":"The mechanism of \u03b3-secretase dysfunction in familial Alzheimer disease","volume":"31","author":"Ch\u00e1vez-Guti\u00e9rrez","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2020.104785_bb0035","doi-asserted-by":"crossref","first-page":"36521","DOI":"10.1074\/jbc.M205093200","article-title":"Presenilin 1 mutations activate \u03b342-secretase but reciprocally inhibit \u03b5-secretase cleavage of amyloid precursor protein (APP) and S3-cleavage of notch","volume":"277","author":"Chen","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2020.104785_bb0040","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s12035-014-8969-1","article-title":"G206D mutation of Presenilin-1 reduces pen 2 interaction, increases A\u03b242\/A\u03b240 ratio and elevates ER Ca2+ accumulation","volume":"52","author":"Chen","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2020.104785_bb0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/34910","article-title":"Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein","volume":"391","author":"De Strooper","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2020.104785_bb0050","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1523\/JNEUROSCI.22-09-03445.2002","article-title":"Neuronal deficiency of Presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V7171] transgenic mice","volume":"22","author":"Dewachter","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104785_bb0055","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.nbd.2020.104785_bb0060","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/gps.657","article-title":"Very early-onset familial Alzheimer\u2019s disease\u202f: a novel presenilin 1 mutation","volume":"17","author":"Goldman","year":"2002","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.nbd.2020.104785_bb0065","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.neurobiolaging.2008.06.012","article-title":"Genetic screening of Alzheimer\u2019s disease genes in Iberian and African samples yields novel mutations in presenilins and APP","volume":"31","author":"Guerreiro","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2020.104785_bb0070","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/bit.25490","article-title":"Highly efficient targeted chromosome deletions using CRISPR\/Cas9","volume":"112","author":"He","year":"2015","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.nbd.2020.104785_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/35017105","article-title":"Total inactivation of \u03b3\u2013secretase activity in presenilin-deficient embryonic stem cells","volume":"2","author":"Herreman","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.nbd.2020.104785_bb0080","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1242\/jcs.00292","article-title":"\u03b3-Secretase activity requires the presenilin-dependent trafficking of nicastrin through the Golgi apparatus but not its complex glycosylation","volume":"116","author":"Herreman","year":"2003","journal-title":"J. Cell Sci."},{"issue":"77","key":"10.1016\/j.nbd.2020.104785_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002369","article-title":"Alzheimer\u2019s disease: the challenge of the second century","volume":"3","author":"Holtzman","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2020.104785_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-018-0392-9","article-title":"Discovery and validation of autosomal dominant Alzheimer\u2019s disease mutations","volume":"10","author":"Hsu","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.nbd.2020.104785_bb0095","first-page":"1","article-title":"A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP \u03b2-CTFs, not A\u03b2","author":"Kwart","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2020.104785_bb0100","doi-asserted-by":"crossref","first-page":"W272","DOI":"10.1093\/nar\/gkw398","article-title":"CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering","volume":"44","author":"Labun","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2020.104785_bb0105","doi-asserted-by":"crossref","first-page":"22475","DOI":"10.1074\/jbc.M300974200","article-title":"Presenilin-1 and Presenilin-2 exhibit distinct yet overlapping \u03b3-secretase activities","volume":"278","author":"Lai","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2020.104785_bb0110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.nbd.2017.04.020","article-title":"Deletion of exons 9 and 10 of the Presenilin 1 gene in a patient with early-onset Alzheimer disease generates longer amyloid seeds","volume":"104","author":"Le Guennec","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.104785_bb0115","doi-asserted-by":"crossref","first-page":"11276","DOI":"10.1074\/jbc.RA119.008041","article-title":"Individual and combined presenilin 1 and 2 knockouts reveal that both have highly overlapping functions in HEK293T cells","volume":"294","author":"Lessard","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2020.104785_bb0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14712598.2018.1389885","article-title":"The potential of solanezumab and gantenerumab to prevent Alzheimer\u2019s disease in people with inherited mutations that cause its early onset","volume":"18","author":"Panza","year":"2018","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.nbd.2020.104785_bb0125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3346\/jkms.2008.23.2.213","article-title":"Identification of PSEN1 and APP gene mutations in Korean patients with early-onset Alzheimer\u2019s disease","volume":"23","author":"Park","year":"2008","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.nbd.2020.104785_bb0130","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jmg.2005.033456","article-title":"Molecular diagnosis of autosomal dominant early onset Alzheimer\u2019s disease: an update","volume":"42","author":"Raux","year":"2005","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.nbd.2020.104785_bb0135","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0092-8674(00)80244-5","article-title":"Skeletal and CNS defects in Presenilin-1-deficient mice","volume":"89","author":"Shen","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2020.104785_bb0140","article-title":"PEN-2 is an integral component of the \u03b3-secretase complex required for coordinated expression of Presenilin and Nicastrin","volume":"293","author":"Steiner","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2020.104785_bb0145","first-page":"E476","article-title":"Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of A\u03b242 and A\u03b240 peptides by \u03b3-secretase","volume":"114","author":"Sun","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2020.104785_bb0150","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1084\/jem.20150892","article-title":"Qualitative changes in human \u03b3-secretase underlie familial Alzheimer\u2019s disease","volume":"212","author":"Szaruga","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2020.104785_bb0155","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.trci.2018.02.002","article-title":"A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer\u2019s disease, including a placebo-treated noncarrier cohort","volume":"4","author":"Tariot","year":"2018","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.nbd.2020.104785_bb0160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2144\/00291bm09","article-title":"Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and Tris (hot SHOT)","volume":"29","author":"Truett","year":"2000","journal-title":"Biotechniques"},{"key":"10.1016\/j.nbd.2020.104785_bb0165","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neuron.2016.03.010","article-title":"Familial Alzheimer\u2019s disease mutations in Presenilin generate Amyloidogenic A\u03b2 peptide seeds","volume":"90","author":"Veugelen","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2020.104785_bb0170","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1471-4159.2004.02858.x","article-title":"Presenilin 2 familial Alzheimer\u2019s disease mutations result in partial loss of function and dramatic changes in A\u03b2 42\/40 ratios","volume":"92","author":"Walker","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2020.104785_bb0175","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1093\/nar\/gng154","article-title":"A PCR primer bank for quantitative gene expression analysis","volume":"31","author":"Wang","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2020.104785_bb0180","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.nbd.2003.12.008","article-title":"Conserved \u201cPAL\u201d sequence in presenilins is essential for \u03b3-secretase activity, but not required for formation or stabilization of \u03b3-secretase complexes","volume":"15","author":"Wang","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.104785_bb0185","doi-asserted-by":"crossref","first-page":"244.e15","DOI":"10.1016\/j.neurobiolaging.2017.10.011","article-title":"Genetic screening in two Iranian families with early-onset Alzheimer\u2019s disease identified a novel PSEN1 mutation","volume":"62","author":"Wang","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2020.104785_bb0190","doi-asserted-by":"crossref","first-page":"15912","DOI":"10.1523\/JNEUROSCI.3261-14.2014","article-title":"Partial loss of Presenilin impairs age-dependent neuronal survival in the cerebral cortex","volume":"34","author":"Watanabe","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104785_bb0195","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.celrep.2013.10.018","article-title":"The presenilin-1 \u0394E9 mutation results in reduced \u03b3-secretase activity, but not total loss of PS1 function, in isogenic human stem cells","volume":"5","author":"Woodruff","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2020.104785_bb0200","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/JAD-2011-102031","article-title":"Clinical phenotype of G206D mutation in the Presenilin 1 gene in pathologically confirmed familial Alzheimer\u2019s disease","volume":"25","author":"Wu","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2020.104785_bb0205","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0896-6273(01)00417-2","article-title":"APP processing and synaptic plasticity in Presenilin-1 conditional knockout mice","volume":"31","author":"Yu","year":"2001","journal-title":"Neuron"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120300607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120300607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:18:11Z","timestamp":1760851091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996120300607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":41,"alternative-id":["S0969996120300607"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104785","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104785"}}